Yüklüyor......
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
Drug delivery to malignant tumors is limited by several factors, including off-target toxicities and suboptimal benefits to cancer patient. Major research efforts have been directed toward developing novel technologies involving nanoparticles (NPs) to overcome these challenges. Major obstacles, howe...
Kaydedildi:
| Yayımlandı: | Front Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6196266/ https://ncbi.nlm.nih.gov/pubmed/30374303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01154 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|